Quantitative Analysis of Lipids: A Higher-Throughput LC–MS/MS-Based Method and its Comparison to ELISA

References

• Ganesh T. Prostanoid receptor EP2 as a therapeutic target. J. Med. Chem. 57(11), 4454–4465 (2014).
   PubMed Web of Science ®Google Scholar
• Minghetti L. Role of inflammation in neurodegenerative diseases. Curr. Opin. Neurol. 18(3), 315–321 (2005).
   PubMed Web of Science ®Google Scholar
• Lucas SM, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br. J. Pharmacol. 147(Suppl. 1), S232–S240 (2006).
   PubMedGoogle Scholar
• Tabas I, Glass CK. Anti-inflammatory therapy in chronic disease: challenges and opportunities. Science 339(6116), 166–172 (2013).
   PubMed Web of Science ®Google Scholar
• Kidd BL, Urban LA. Mechanisms of inflammatory pain. Br. J. Anaesth. 87(1), 3–11 (2001).
   PubMed Web of Science ®Google Scholar
• Ricciotti E, FitzGerald GA. Prostaglandins and inflammation. Arterioscler. Thromb. Vasc. Biol. 31(5), 986–1000 (2011).
   PubMed Web of Science ®Google Scholar
• Hall A, Brown SH, Budd C et al. Discovery of GSK345931A: an EP(1) receptor antagonist with efficacy in preclinical models of inflammatory pain. Bioorg. Med. Chem. Lett. 19(2), 497–501 (2009).
   PubMed Web of Science ®Google Scholar
• Kawabata A. Prostaglandin E2 and pain – an update. Biol. Pharm. Bull. 34(8), 1170–1173 (2011).
   PubMed Web of Science ®Google Scholar
• Kunori S, Matsumura S, Okuda-Ashitaka E et al. A novel role of prostaglandin E2 in neuropathic pain: blockade of microglial migration in the spinal cord. Glia 59(2), 208–218 (2011).
   PubMed Web of Science ®Google Scholar
• Fisher M, Zipser R. Increased excretion of immunoreactive thromboxane B2 in cerebral ischemia. Stroke 16(1), 10–14 (1985).
   PubMed Web of Science ®Google Scholar
• Eguchi N, Hayashi H, Urade Y, Ito S, Hayaishi O. Central action of prostaglandin E2 and its methyl ester in the induction of hyperthermia after their systemic administration in urethane-anesthetized rats. J. Pharmacol. Exp. Ther. 247(2), 671–679 (1988).
   PubMed Web of Science ®Google Scholar
• Faupel-Badger JM, Fuhrman BJ, Xu X et al. Comparison of liquid chromatography-tandem mass spectrometry, RIA, and ELISA methods for measurement of urinary estrogens. Cancer Epidemiol. Biomarkers Prev. 19(1), 292–300 (2010).
   PubMed Web of Science ®Google Scholar
• Squellerio I, Porro B, Songia P et al. Liquid chromatography-tandem mass spectrometry for simultaneous measurement of thromboxane B2 and 12(S)-hydroxyeicosatetraenoic acid in serum. J. Pharm. Biomed. Anal. 96, 256–262 (2014).
   PubMed Web of Science ®Google Scholar
• Thomas D, Suo J, Ulshofer T et al. Nano-LC–MS/MS for the quantitation of prostanoids in immune cells. Anal. Bioanal. Chem. 406(28), 7103–7116 (2014).
   PubMed Web of Science ®Google Scholar
• Willenberg I, Meschede AK, Schebb NH. Determining cyclooxygenase-2 activity in three different test systems utilizing online-solid phase extraction-liquid chromatography-mass spectrometry for parallel quantification of prostaglandin E(2), D(2) and thromboxane B(2). J. Chromatogr. A 1391, 40–48 (2015).
   PubMed Web of Science ®Google Scholar
• Schmidt R, Coste O, Geisslinger G. LC–MS/MS-analysis of prostaglandin E2 and D2 in microdialysis samples of rats. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 826(1–2), 188–197 (2005).
   PubMed Web of Science ®Google Scholar
• Cao H, Xiao L, Park G et al. An improved LC–MS/MS method for the quantification of prostaglandins E(2) and D(2) production in biological fluids. Anal. Biochem. 372(1), 41–51 (2008).
   PubMed Web of Science ®Google Scholar
• Jian W, Edom RW, Xue X, Huang MQ, Fourie A, Weng N. Quantitation of leukotriene B(4) in human sputum as a biomarker using UPLC–MS/MS. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 932, 59–65 (2013).
   PubMed Web of Science ®Google Scholar
• Lin W, Huang MQ, Xue X et al. A highly sensitive and selective method for the determination of leukotriene B4 (LTB4) in ex vivo stimulated human plasma by ultra fast liquid chromatography-tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 925, 54–62 (2013).
   PubMed Web of Science ®Google Scholar
• Yue H, Strauss KI, Borenstein MR, Barbe MF, Rossi LJ, Jansen SA. Determination of bioactive eicosanoids in brain tissue by a sensitive reversed-phase liquid chromatographic method with fluorescence detection. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 803(2), 267–277 (2004).
   PubMed Web of Science ®Google Scholar
• Masoodi M, Nicolaou A. Lipidomic analysis of 27 prostanoids and isoprostanes by liquid chromatography/electrospray tandem mass spectrometry. Rapid Commun. Mass. Spectrom. 20(20), 3023–3029 (2006).
   PubMed Web of Science ®Google Scholar
• Möller T, Hanisch UK, Ransom BR et al. Thrombin-induced activation of cultured rodent microglia.. J. Neurochem. 75(4), 1539–1547 (2000).
   PubMed Web of Science ®Google Scholar
• Bennett GJ, Xie YK. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33(1), 87–107 (1988).
   PubMed Web of Science ®Google Scholar
• Brose SA, Thuen BT, Golovko MY et al. LC/MS/MS method for analysis of E? series prostaglandins and isoprostanes. J. Lipid Res. 52(4), 850–859 (2011).
   PubMed Web of Science ®Google Scholar
• John H, Schlegel W. Reversed-phase high-performance liquid chromatographic method for the determination of the 11-hydroxythromboxane B2 anomers equilibrium. J. Chromatogr. B Biomed. Sci. Appl. 698(1–2), 9–15 (1997).
   PubMed Web of Science ®Google Scholar
• Houghton R, Horro PC, Ward I. Genericapproach to validation of small-molecule LC-MS/MS biomarker assays. Bioanalysis 1(8), 1365–1374 (2009).
   PubMed Web of Science ®Google Scholar
• Tanaka T, Ito S, Hiroshima O, Hayashi H, Hayaishi O. Rat monoclonal antibody specific for prostaglandin E structure. Biochim. Biophys. Acta 836(1), 125–133 (1985).
   PubMedGoogle Scholar